Oral squamous cell carcinoma (OSCC) is a highly malignant and invasive tumor with significant mortality and morbidity. Current treatment modalities such as surgery, radiotherapy, and chemotherapy encounter significant limitations, such as poor targeting, systemic toxicity, and drug resistance. There is an urgent need for novel therapeutic strategies that offer targeted delivery, enhanced efficacy, and reduced side effects. The advent of lipid-based nanoparticles (LNPs) offers a promising tool for OSCC therapy, potentially overcoming the limitations of current therapeutic approaches. LNPs are composed of biodegradable and biocompatible lipids, which minimize the risk of toxicity and adverse effects. LNPs can encapsulate hydrophobic drugs, improving their solubility and stability in the biological environment, thereby enhancing their bioavailability. LNPs demonstrate significantly higher ability to encapsulate lipophilic drugs than other nanoparticle types. LNPs offer excellent storage stability, minimal drug leakage, and controlled drug release, making them highly effective nanoplatforms for the delivery of chemotherapeutic agents. Additionally, LNPs can be modified by complexing them with specific target ligands on their surface. This surface modification allows the active targeting of LNPs to the tumors in addition to the passive targeting mechanism. Furthermore, the PEGylation of LNPs improves their hydrophilicity and enhances their biological half-life by reducing clearance by the reticuloendothelial system. This review aims to discuss current treatment approaches and their limitations, as well as recent advancements in LNPs for better management of OSCC.
oral squamous cell carcinomalipid nanoparticlestargeted drug deliverychemotherapy
Clinical Case Reports · مجلد 12 (11) · e9378-e9378
Key Clinical Message: It is important to consider the diagnosis of Sump syndrome in patients with a history of open cholecystectomy, particularly in those who migrate from developing countries where alternative biliary interventions may be limited. The presentation may range from acute severe, mimicking acute ascending cholangitis, to chronic recurrent abdominal pain without evidence of inflammation. Management is a case-by-case decision, with principal management aims to decompress the biliary tract and address any underlying sepsis. Abstract: Sump syndrome is a rare and often long-term complication of choledochoduodenostomy (CDD). The presentation and severity are variable, and management should be tailored to each patient based on several factors. Herein, we report three cases of sump syndrome, each demonstrating unique diagnostic dilemmas and therapeutic modalities. Case I describes a woman presenting with acute cholangitis, managed with percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP). Case II illustrates a similar presentation complicated by myocardial infarction, necessitating urgent biliary decompression via PTC and subsequent unsuccessful endoscopic stenting. Case III highlights the diagnostic difficulty in a stable patient with inconclusive diagnostic imaging. This case series emphasizes the importance of considering sump syndrome diagnosis in patients with a history of CDD or open cholecystectomy, especially in elderly patients and those who come from regions where alternative biliary interventions may be limited.
In vascular neurosurgery, dural arteriovenous fistulas (DAVFs) are a difficult, challenging condition whose natural history and therapy are still debated. This case report presented a 30-year-old male patient who experienced intermittent headaches for two months, along with gradual weakness in all four limbs, resulting in quadriplegia. Magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA) played a significant role in the diagnosis of the patient, in which the final diagnosis was vascular myelopathy due to Dural arteriovenous fistula (DAVF). A successful embolization procedure of arteriovenous fistula using balloon-assisted liquid embolic agents, through branches of the right occipital artery was performed, resulting in complete obliteration of the fistula. In order to improve the neurovascular symptoms that had previously been reported, the patient was effectively undergoing rehabilitation, with notable progress.
Journal of Advanced Trends in Medical Research · مجلد 1 (3) · 784-790
Abstract Background: Traumatic brain injury (TBI) in children is still a major concern amongst healthcare worldwide as it causes raised morbidity and mortality rate. Identification of TBI cases is therefore paramount in treatment with diagnostic imaging techniques such as the computed tomography (CT) and magnetic resonance imaging (MRI) amongst others. However, deciding between the two methods has been a challenge since radiation exposure by CT and the limitation of MRI, which include longer time for scan and most importantly, need for use of sedation amongst children. This review aims at analysing and comparing accuracy of CT and MRI in diagnosing paediatric TBI; the effects of the two MRI scans on prognosis and the contribution of the two scans in management decision-making. Furthermore, the views on safety issues connected with radiation in CT as well as whether the modern MRI methods can improve the diagnostic potential without safety issues are also discussed. Methods: A literature search using the PubMed, Scopus and Google Scholar databases was done with terms such as ‘point of care’, ‘clinical decision support’, ‘decision support system’ was used with an emphasis on articles published in the past 15 years. Article titles used were ‘paediatric traumatic brain injury’, ‘CT in paediatric TBI’, ‘MRI in paediatric TBI’ and ‘diagnostic accuracy of imaging in TBI’. The review of articles involved only patients aged between 0 and 18 years diagnosed with TBI through CT or MRI that provided data on diagnostic accuracy, clinical management and safety considerations. Results: CT is used in the management of acute TBI because it is fast and widely available, especially for instance in emergency situations. MRI, however, has the advantages of producing higher sensitivity in identification of diffuse axonal injuries and less evident pathologies of the brain that may not be identified in a CT. However, MRI has limitations such as long time to perform a scan, is expensive and requires administration of sedatives to children making it less suitable for use in the acute care settings. Third, despite its effectiveness, CT exposes the patient to radiation that increases his/her chances of getting cancer especial if the patient is a child. Newer techniques in MRI have emerged which enhance the capacity of diagnosis of paediatric TBI and its further management and prognosis; these are the diffusion tensor imaging and susceptibility-weighted imaging. Conclusions: CT and MRI should both be used in the evaluation of paediatric TBI because they each provide information that the other cannot. CT scan has remained the primary imaging modality in the acute setting because of the speed in availability and to assess the critical lesions, whereas MRI offers a detailed examination of TBI important in the post-acute phase. This review is helpful in establishing possible guidelines that will help in the use of these imaging techniques in paediatric TBI that will enhance the detection of the injury without exposing the patients to additional harm. More investigation is, therefore, required to standardise the techniques and protocols that improve the efficiency of imaging procedures for therapeutic processes, while avoiding adverse effects such as radiation hazards.